Stanford Study Evaluates Combined Treatment of Insomnia and Depression
Posted on: Wednesday, 7 September 2005, 15:01 CDT
Getting a good night's sleep may help improve your outlook on life, but it's easier said than done if you suffer from both insomnia and depression.
In a first-of-its-kind study, a Stanford University School of Medicine researcher is exploring innovative ways to tackle the problem of these two disorders together. Rachel Manber, PhD, associate professor of psychiatry and behavioral sciences, is seeking volunteers for a study of the benefits of combining treatment of psychotherapy for insomnia and medication for depression.
"Between 60 and 84 percent of patients with major depression are troubled by difficulty initiating and/or maintaining sleep," said Manber. "Insomnia adversely affects the course of standard antidepressant therapy. Studies have repeatedly shown that poor sleep is associated with slower and lower rates of remission from depression."
For the study, Manber hopes to enroll 58 participants who suffer from insomnia and depression, are between the ages of 18 and 75, are generally in good health and are not currently receiving treatment for either of the two disorders.
During the study, the qualified participants will receive free evaluations of their sleep, including an at-home, all-night sleep study. Participants will also receive 12 weeks of an FDA-approved antidepressant medication for depression (escitalopram oxalate or Lexapro) and will be randomized into receiving seven sessions of one of two forms of sleep-focused psychotherapies for insomnia.
Interested men and women should contact study coordinator Melanie San Pedro at msanpedro@stanford.edu or (650) 724-9774 for a free telephone screening.
The study is funded by the National Institute of Mental Health.
Stanford University Medical Center integrates research, medical education and patient care at its three institutions -- Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital at Stanford. For more information, please visit the Web site of the medical center's Office of Communication & Public Affairs at http://mednews.stanford.edu.
Source: Business Wire
Related Articles
- NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate
- AtStaff Announces That The University of Virginia Medical Center Has Selected ClairVia(R) Staff and Demand Management Software to Support Its Mission of Excellence and Innovation in Patient Care
- Aetna Adds University of Chicago Medical Center to Illinois Network
- Life in Motion Movement Disorders Interactive Experience Center Comes to Cleveland's University Hospitals Case Medical Center
- Study: 3rd Depression Drug Rarely Helps
- University of Pittsburgh Medical Center Expands Its Reach in Qatar
- CytoGenix and the University of Texas Medical Branch at Galveston Sign Agreement for Preclinical Testing of synDNA(TM) H5N1 Avian Flu Vaccine Candidates
- University of Pittsburgh Medical Center Las Vegas Hospital Venture Hits Bump
- Ciphergen and University of Texas Medical Branch at Galveston Sign Collaboration Agreement in Liver Disease
- Daxor Announces That the University of Maryland Medical Center, Baltimore, Maryland, to Begin Heart Failure Treatment Research Utilizing Daxor's BVA-100 Blood Volume Analyzer
 |
 |
User Comments (0)
RSS Feeds